Navigation Links
Massive necrosis after trans-catheter treatment is more common in the presence of tumor capsule
Date:11/23/2007

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. Prognosis of patients with HCC complicating cirrhosis mainly depends on the tumor growth, progression of the underlying liver disease and the effectiveness of antitumoral treatment. Trans-catheter treatment is extensively used to treat HCC not suitable for surgical resection or percutaneous ablation therapies. Unfortunately, the tumor response after trans-catheter treatment is heterogeneous, with a wide range of necrosis that cannot be accurately predicted.

A study, published on the issue 45 of World Journal of Gastroenterology, led by Dr. Roberto Miraglia from the Mediterranean Institute for Transplantation and Advanced Specialized Therapies, evaluated the pre-treatment imaging and clinical variables of two hundred cirrhotic patients with HCC underwent trans-catheter treatment. The research showed that massive necrosis after trans-catheter treatment is more common in the presence of tumor capsule, with a maximum diameter of the main lesion between 2 - 6 cm, CLIP score < 2 and the absence of constitutional syndrome. The ability to predict which patients could respond to trans-catheter treatment could be useful in clinical decision making and to stratify patient randomization in therapeutic clinical trials.


'/>"/>

Contact: You-De Chang
y.d.chang@wjgnet.com
0086-108-538-1892
World Journal of Gastroenterology
Source:Eurekalert

Page: 1

Related medicine news :

1. Michigan Catholic Conference Launches Massive Internal Stem Cell Education Program
2. Work-Family Conflict Dogs Air Force Women After Deployment
3. Work-Family Conflict Dogs Air Force Women After Deployment
4. Stopping Statins After Stroke Doubles Death Risk
5. Billy Graham Home After Hospitalization:
6. Swelling After Knee Injury May Hinder Healing
7. Going on After Loss
8. Vitamin Relief Brings Needed Nutrition to School District Resurrecting After Katrina
9. Discover The Mutter Museum After Dark
10. Cialis Eases Erectile Dysfunction After Spinal Cord Injury
11. Perrigo Vice Chair Mori Arkin To Retire After 30 Years of Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
Breaking Medicine Technology: